Company news
Resonance Health Ltd (ASX:RHT) news
Resonance Health Ltd news releases on 6ix. Latest, Sep 16, 2026: Global Strategic Alliance & MSA with Image Analysis Group
Press releases & updates
Global Strategic Alliance & MSA with Image Analysis Group
September 16, 2026
FY26 Full Year Results & Investor Webinar
August 27, 2026
Liver Fibrosis Device Progress & FY26 Portfolio Webinar
June 8, 2026
Profit Guidance Upgrade
May 5, 2026
Receipt of R&D Tax Incentive Refund
March 16, 2026
Half Year Results Presentation
February 26, 2026
Half Year Results
February 26, 2026
Half Year Report & Accounts
February 26, 2026
Quarterly Activities/Appendix 4C Cash Flow Report
January 29, 2026
AGM Presentation
November 13, 2025
Investor Strategy Day Presentation
October 13, 2025
FY25 Full Year Results & FY26 Guidance Investor Presentation
August 29, 2025
Appendix 4E & Full Year Statutory Accounts
August 29, 2025
TrialsWest Expands with New Clinical Trial Site
July 8, 2025
Half Yearly Report and Accounts
February 27, 2025
Non-deal Investor Roadshow Presentation
December 1, 2024
Resonance Contracted by Major Global Pharma
November 18, 2024
Trading Halt
November 17, 2024
Full Year Results Presentation
August 29, 2024
Full Year Results
August 29, 2024
Appendix 4E & Annual Report to Shareholders
August 29, 2024
TrialsWest Expansion - New Trial Site
August 8, 2024
Completion of TrialsWest Acquisition
May 31, 2024
Investor Presentation - TrialsWest Acquisition
April 2, 2024
Acquisition of TrialsWest Group
April 2, 2024
Pause in Trading
March 28, 2024
Collaboration with Micron, Inc.
March 27, 2024
Half Yearly Report Results Announcement
February 28, 2024
Notification of buy-back - RHT
November 24, 2023
Annual Report & Appendix 4E
August 29, 2023
Management Transition
June 22, 2023
MRI Fibrosis Provisional Patent Application Lodged
December 20, 2022
Investor Presentation
November 24, 2022
Resonance Health Contracted for Two New Clinical Trials
November 10, 2022
Preliminary Final Report
August 30, 2022
FerriScan Now Available on 3 Tesla (3T) MRI Machines
July 24, 2022
Resonance Health : Quarterly Activities/Appendix 4C Cash Flow Report
May 1, 2022
Platform Integration & Partnership Agreement with CARPL.ai
April 4, 2022
US CPT Code Confirmation for LiverSmart
February 6, 2022
Resonance Health Enters China - Pharma Contract Signed
January 27, 2022
Resonance Health Contracted for Third Party Clinical Trial
January 24, 2022
US FDA Clearance for LiverSmart
December 29, 2021
ASO Project New Data
December 19, 2021
LiverSmart Submitted to FDA for US Regulatory Clearance
December 2, 2021
Investor Presentation - Positioning for Growth
November 25, 2021
ASO R&D Project - Filing of Two Patent Applications
November 22, 2021
Thalassaemia International Federation to Deploy FerriSmart
November 11, 2021
Sales & Marketing Update
October 13, 2021
New AI Medical Device
October 12, 2021
Resonance Health : Appointment of GM - Global Sales & Marketing
July 27, 2021